Cytokine and chemokine expression in a rat endometriosis is similar to that in human endometriosis

Cytokine

Volumn 43, Issue 2, 2008, Pages 105-109

  Umezawa, Masakazu ^a,b   Sakata, Chika ^a,b   Tanaka, Naomi ^a,b   Kudo, Sayaka ^b   Tabata, Masako ^b   Takeda, Ken ^b   Ihara, Tomomi ^a   Sugamata, Masao ^a  

^a Tochigi Institute of Clinical Pathology   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Autotransplantation; Cytokine; Endometriosis; Rat model; Serum monocyte chemoattractant protein (MCP) 1

Indexed keywords

CHEMOKINE; CYTOKINE; EOSINOPHIL CHEMOTACTIC FACTOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOGRAFT; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMAN VERSUS ANIMAL COMPARISON; NONHUMAN; PATHOGENESIS; PERITONEUM; PRIORITY JOURNAL; RAT; UPREGULATION;

ANIMALS; CYTOKINES; ENDOMETRIOSIS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 48049095701     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.04.016     Document Type: Article

References (47)

1. Giudice L.C., and Kao L.C. Endometriosis. Lancet 364 (2004) 1789-1799
2. Sampson J.A. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 14 (1927) 422-469
3. Vernon M.W., and Wilson E.A. Studies on the surgical induction of endometriosis in the rat. Fertil Steril 44 (1985) 684-694
4. Uchiide I., Ihara T., and Sugamata M. Pathological evaluation of the rat endometriosis model. Fertil Steril 78 (2002) 782-786
5. Sugamata M., Ihara T., and Uchiide I. Increase of activated mast cells in human endometriosis. Am J Reprod Immunol 53 (2005) 120-125
6. Hirano T., Taga T., Nakano N., Yasukawa K., Kashiwamura S., Shimizu K., et al. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci USA 82 (1985) 5490-5494
7. Odukoya O.A., Ajjan R., Lim K., Watson P.F., Weetman A.P., and Cooke I.D. The pattern of cytokine mRNA expression in ovarian endometriomata. Mol Hum Reprod 3 (1997) 393-397
8. Tseng J.F., Ryan I.P., Milam T.D., Murai J.T., Schriock E.D., Landers D.V., et al. Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis. J Clin Endocrinol Metab 81 (1996) 1118-1122
9. Bedaiwy M.A., Falcone T., Sharma R.K., Goldberg J.M., Attaran M., Nelson D.R., et al. Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod 17 (2002) 426-431
10. Rier S.E., Zarmakoupis P.N., Hu X., and Becker J.L. Dysregulation of interleukin-6 responses in ectopic endometrial stromal cells: correlation with decreased soluble receptor levels in peritoneal fluid of women with endometriosis. J Clin Endocrinol Metab 80 (1995) 1431-1437
11. Punnonen J., Teisala K., Ranta H., Bennett B., and Punnonen R. Increased levels of interleukin-6 and interleukin-10 in the peritoneal fluid of patients with endometriosis. Am J Obstet Gynecol 174 (1996) 1522-1526
12. Mosmann T.R. Properties and functions of interleukin-10. Adv Immunol 56 (1994) 1-26
13. Podgaec S., Abrao M.S., Dias Jr. J.A., Rizzo L.V., de Oliveira R.M., and Baracat E.C. Endometriosis: an inflammatory disease with a Th2 immune response component. Hum Reprod 22 (2007) 1373-1379
14. Hsu C.C., Yang B.C., Wu M.H., and Huang K.E. Enhanced interleukin-4 expression in patients with endometriosis. Fertil Steril 67 (1997) 1059-1064
15. Antsiferova Y.S., Sotnikova N.Y., Posiseeva L.V., and Shor A.L. Changes in the T-helper cytokine profile and in lymphocyte activation at the systemic and local levels in women with endometriosis. Fertil Steril 84 (2005) 1705-1711
16. Yoshimura T., and Leonard E.J. Secretion by human fibroblasts of monocyte chemoattractant protein-1, the product of gene JE. J Immunol 144 (1990) 2377-2383
17. Arici A., MacDonald P.C., and Casey M.L. Regulation of monocyte chemotactic protein-1 gene expression in human endometrial cells in cultures. Mol Cell Endocrinol 107 (1995) 189-197
18. Arici A., Oral E., Attar E., Tazuke S.I., and Olive D.L. Monocyte chemotactic protein-1 concentration in peritoneal fluid of women with endometriosis and its modulation of expression in mesothelial cells. Fertil Steril 67 (1997) 1065-1072
19. Matsushima K., Larsen C.G., DuBois G.C., and Oppenheim J.J. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 169 (1989) 1485-1490
20. Yoshimura T., Robinson E.A., Tanaka S., Appella E., Kuratsu J., and Leonard E.J. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J Exp Med 169 (1989) 1449-1459
21. Carr M.W., Roth S.J., Luther E., Rose S.S., and Springer T.A. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA 91 (1994) 3652-3656
22. Allavena P., Bianchi G., Zhou D., van Damme J., Jílek P., Sozzani S., et al. Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3. Eur J Immunol 24 (1994) 3233-3236
23. Maghazachi A.A., al-Aoukaty A., and Schall T.J. C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells. Role for G proteins. J Immunol 153 (1994) 4969-4977
24. Gu L., Tseng S., Horner R.M., Tam C., Loda M., and Rollins B.J. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404 (2000) 407-411
25. Akoum A., Lemay A., McColl S.R., Paradis I., and Maheux R. Increased monocyte chemotactic protein-1 level and activity in the peripheral blood of women with endometriosis. Le Groupe d'Investigation en Gynécologie. Am J Obstet Gynecol 175 (1996) 1620-1625
26. Pizzo A., Salmeri F.M., Ardita F.V., Sofo V., Tripepi M., and Marsico S. Behaviour of cytokine levels in serum and peritoneal fluid of women with endometriosis. Gynecol Obstet Invest 54 (2002) 82-87
27. Konno R., Yamada-Okabe H., Fujiwara H., Uchiide I., Shibahara H., Ohwada M., et al. Role of immunoreactions and mast cells in pathogenesis of human endometriosis-morphologic study and gene expression analysis. Hum Cell 16 (2003) 141-149
28. Gmyrek G.B., Sozanski R., Jerzak M., Chrobak A., Wickiewicz D., Skupnik A., et al. Evaluation of monocyte chemotactic protein-1 levels in peripheral blood of infertile women with endometriosis. Eur J Obstet Gynecol Reprod Biol 122 (2005) 199-205
29. Garcia-Velasco J.A., Seli E., and Arici A. Regulation of monocyte chemotactic protein-1 expression in human endometrial stromal cells by integrin-dependent cell adhesion. Biol Reprod 61 (1999) 548-552
30. Selam B., Kayisli U.A., Akbas G.E., Basar M., and Arici A. Regulation of FAS ligand expression by chemokine ligand 2 in human endometrial cells. Biol Reprod 75 (2006) 203-209
31. Ponath P.D., Qin S., Post T.W., Wang J., Wu L., Gerard N.P., et al. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med 183 (1996) 2437-2448
32. Zhang J., Lathbury L.J., and Salamonsen L.A. Expression of the chemokine eotaxin and its receptor, CCR3, in human endometrium. Biol Reprod 62 (2000) 404-411
33. Mattoli S., Stacey M.A., Sun G., Bellini A., and Marini M. Eotaxin expression and eosinophilic inflammation in asthma. Biochem Biophys Res Commun 236 (1997) 299-301
34. Conroy D.M., and Williams T.J. Eotaxin and the attraction of eosinophils to the asthmatic lung. Respir Res 2 (2001) 150-156
35. Blumenthal R.D., Samoszuk M., Taylor A.P., Brown G., Alisauskas R., and Goldenberg D.M. Degranulating eosinophils in human endometriosis. Am J Pathol 156 (2000) 1581-1588
36. Hornung D., Dohrn K., Sotlar K., Greb R.R., Wallwiener D., Kiesel L., et al. Localization in tissues and secretion of eotaxin by cells from normal endometrium and endometriosis. J Clin Endocrinol Metab 85 (2000) 2604-2608
37. Schall T.J., Jongstra J., Dyer B.J., Jorgensen J., Clayberger C., Davis M.M., et al. A human T cell-specific molecule is a member of a new gene family. J Immunol 141 (1988) 1018-1025
38. Schall T.J., Bacon K., Toy K.J., and Goeddel D.V. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347 (1990) 669-671
39. Kameyoshi Y., Dörschner A., Mallet A.I., Christophers E., and Schröder J.M. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 176 (1992) 587-592
40. Ortiz B.D., Krensky A.M., and Nelson P.J. Kinetics of transcription factors regulating the RANTES chemokine gene reveal a developmental switch in nuclear events during T-lymphocyte maturation. Mol Cell Biol 16 (1996) 202-210
41. Khorram O., Taylor R.N., Ryan I.P., Schall T.J., and Landers D.V. Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis. Am J Obstet Gynecol 169 (1993) 1545-1549
42. Halme J., Becker S., and Haskill S. Altered maturation and function of peritoneal macrophages: possible role in pathogenesis of endometriosis. Am J Obstet Gynecol 156 (1987) 783-789
43. Halme J., White C., Kauma S., Estes J., and Haskill S. Peritoneal macrophages from patients with endometriosis release growth factor activity in vitro. J Clin Endocrinol Metab 66 (1988) 1044-1049
44. Olive D.L., Montoya I., Riehl R.M., and Schenken R.S. Macrophage-conditioned media enhance endometrial stromal cell proliferation in vitro. Am J Obstet Gynecol 164 (1991) 953-958
45. Maurer M., and von Stebut E. Macrophage inflammatory protein-1. Int J Biochem Cell Biol 36 (2004) 1882-1886
46. Wieser F., Dogan S., Klingel K., Diedrich K., Taylor R.N., and Hornung D. Expression and regulation of CCR1 in peritoneal macrophages from women with and without endometriosis. Fertil Steril 83 (2005) 1878-1881
47. Miyazaki D., Nakamura T., Toda M., Cheung-Chau K.W., Richardson R.M., and Ono S.J. Macrophage inflammatory protein-1α as a costimulatory signal for mast cell-mediated immediate hypersensitivity reactions. J Clin Invest 115 (2005) 434-442